Assessment of the Hong Kong Liver Cancer Staging System in Europe.

Kolly, Philippe; Reeves, Helen; Sangro, Bruno; Knöpfli, Marina Janusheva; Candinas, Daniel; Dufour, Jean-François (2015). Assessment of the Hong Kong Liver Cancer Staging System in Europe. Liver international, 36(6), pp. 911-917. Blackwell Munksgaard 10.1111/liv.13045

[img] Text
Assessment of the Hong Kong Liver Cancer Staging System in Europe..pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.
Download (330kB) | Request a copy

BACKGROUND & AIMS

European and American guidelines have endorsed the Barcelona Clinic Liver Cancer (BCLC) staging system. The aim of this study was to assess the performance of the recently developed Hong Kong Liver Cancer (HKLC) classification as a staging system for hepatocellular carcinoma (HCC) in Europe.

METHODS

We used a pooled set of 1693 HCC patients combining three prospective European cohorts. Discrimination ability between the nine substages and five stages of the HKLC classification system was assessed. To evaluate the predictive power of the HKLC and BCLC staging systems on overall survival, Nagelkerke pseudo R2, Bayesian Information Criterion and Harrell's concordance index were calculated. The number of patients who would benefit from a curative therapy was assessed for both staging system.

RESULTS

The HKLC classification in nine substages shows suboptimal discrimination between the staging groups. The classification in five stages shows better discrimination between groups. However, the BCLC classification performs better than the HKLC classification in the ability to predict OS. The HKLC treatment algorithm tags significantly more patients to curative therapy than the BCLC.

CONCLUSIONS

The BCLC staging system performs better for European patients than the HKLC staging system in predicting OS. Twice more patients are eligible for a curative therapy with the HKLC algorithm, whether this translates in survival benefit remains to be investigated. This article is protected by copyright. All rights reserved.

Item Type:

 Journal Article (Original Article)

Division/Institute:

 04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie
04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Hepatology
04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine
04 Faculty of Medicine > Faculty Institutions > Teaching Staff, Faculty of Medicine
04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Visceral Surgery
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR)

UniBE Contributor:

 Kolly, Philippe (B), Knöpfli, Marina Janusheva, Candinas, Daniel, Dufour, Jean-François

Subjects:

 600 Technology > 610 Medicine & health

ISSN:

 1478-3223

Publisher:

 Blackwell Munksgaard

Language:

 English

Submitter:

 Lilian Karin Smith-Wirth

Date Deposited:

 02 Mar 2016 15:54

Last Modified:

 29 Mar 2023 23:34

Publisher DOI:

 10.1111/liv.13045

PubMed ID:

 26677809

Uncontrolled Keywords:

 BCLC ; HKLC ; hepatocellular carcinoma; liver cancer; staging

BORIS DOI:

 10.7892/boris.77501

URI:

 https://boris.unibe.ch/id/eprint/77501

Actions (login required)

Edit item Edit item
Provide Feedback